Previous studies have shown that ERK/CREB signaling is involved in neuroprotection in various brain injuries and scopolamine-induced memory impairment (Park et al., 2004; Atkins et al., 2009; Li et al., 2016; Deepa et al., 2020). The gene discussed is CREB1; the disease is brain injury.